Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

The Lancet - Tập 358 - Trang 958-965 - 2001
Michael P Manns1, John G McHutchison2, Stuart C Gordon3, Vinod K Rustgi4, Mitchell Shiffman5, Robert Reindollar6, Zachary D Goodman7, Kenneth Koury8, Mei-Hsiu Ling8, Janice K Albrecht8
1Division of Gastroenterology and Hepatology, Medical School of Hannover, Germany
2Scripps Clinic, La Jolla, CA
3William Beaumont Hospital, Royal Oaks, MI
4Georgetown University, Washington, DC
5Medical College Virginia, Richmond, VA
6Charlotte Clinic for Gastrointestinal and Liver Diseases, Charlotte, NC
7Armed Forces Institute of Pathology, Bethesda, Md
8Schering Plough Research Institute, Kenilworth, NJ, USA

Thông tin
Thông tin xuất bản

The Lancet

Tập 358

958-965

Thông tin tác giả